{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:19:11Z","timestamp":1782479951472,"version":"3.54.5"},"reference-count":22,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T00:00:00Z","timestamp":1513728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["III 41020"],"award-info":[{"award-number":["III 41020"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["III 41020"],"award-info":[{"award-number":["III 41020"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Psychopharmacology"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>The objective of this study is to ascertain psychiatrists' treatment preferences for generalized anxiety disorder (GAD) and compare them to the same psychiatrists' treatment preferences in the hypothetical scenario that treatment is to be administered to themselves as patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A questionnaire was completed by 221 psychiatrists from 3 Balkan countries. They were asked to indicate their treatment preferences for patients with GAD and for themselves as patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A large majority of psychiatrists chose selective serotonin reuptake inhibitors\/serotonin and norepinephrine reuptake inhibitors as preferred treatment option for GAD patients. Fewer psychiatrists selected benzodiazepines and pregabalin and about one third chose psychotherapy. The majority of psychiatrists chose the same treatments for their patients and for themselves, with main differences being in terms of pharmacotherapy (especially benzodiazepines) being less frequently recommended and psychotherapy being more frequently recommended as preferred treatment option for psychiatrists as patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Treatment preferences for GAD by psychiatrists in the 3 West Balkan countries were mostly in accordance with treatment guidelines and treatment preferences for patients and for psychiatrists as patients were mostly concordant. However, some psychiatrists were more likely to choose pharmacotherapy for patients and psychotherapy for themselves as patients. These findings have implications for education of psychiatrists and for efforts to improve treatment guidelines and mental health services.<\/jats:p><\/jats:sec>","DOI":"10.1002\/hup.2643","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T05:06:32Z","timestamp":1513832792000},"source":"Crossref","is-referenced-by-count":11,"title":["Psychiatrists' treatment preferences for generalized anxiety disorder"],"prefix":"10.1002","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4386-6256","authenticated-orcid":false,"given":"Milan","family":"Latas","sequence":"first","affiliation":[{"name":"School of Medicine University of Belgrade  Belgrade Serbia"},{"name":"Clinic of Psychiatry Clinical Centre of Serbia  Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Trajkovi\u0107","sequence":"additional","affiliation":[{"name":"School of Medicine University of Belgrade  Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitar","family":"Bonevski","sequence":"additional","affiliation":[{"name":"Psychiatric Hospital \u201cSkopje\u201d Centre for Mental Health \u201cCentar\u201d  Skopje Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andromahi","family":"Naumovska","sequence":"additional","affiliation":[{"name":"Psychiatric Hospital \u201cSkopje\u201d Centre for Mental Health \u201cCentar\u201d  Skopje Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du\u0161anka","family":"Vu\u010dini\u0107 Latas","sequence":"additional","affiliation":[{"name":"Psychiatric Hospital, Clinical Centre \u201cDr Dragisa Misovic \u2013 Dedinje\u201d and Department of Psychology University Singidunum  Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Bukumiri\u0107","sequence":"additional","affiliation":[{"name":"School of Medicine University of Belgrade  Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladan","family":"Star\u010devi\u0107","sequence":"additional","affiliation":[{"name":"Sydney Medical School \u2013 Nepean, Discipline of Psychiatry University of Sydney  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,12,20]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2004.09.035"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2011.624548"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114525674"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-014-0563-z"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2318-9-31"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(90)90159-M"},{"key":"e_1_2_7_8_1","unstructured":"R Core Team(2016).R: A language and environment for statistical computing. R Foundation for Statistical Computing Vienna Austria. Retrieved fromhttps:\/\/www.r-project.org\/"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1201\/9781420035681"},{"key":"e_1_2_7_10_1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-244X-14-S1-S1","article-title":"Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive\u2010compulsive disorders","volume":"14","author":"Katzman M. A.","year":"2014","journal-title":"BMC Psychiatry"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291702006104"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291705004538"},{"issue":"3","key":"e_1_2_7_13_1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2298\/SARH1404204L","article-title":"How do we treat generalized anxiety disorder?","volume":"142","author":"Latas M.","year":"2014","journal-title":"Srpski Arhiv za Celokupno Lekarstvo"},{"issue":"2","key":"e_1_2_7_14_1","first-page":"182","article-title":"Psychiatrists' psychotropic drug prescription preferences for themselves or their family members","volume":"24","author":"Latas M.","year":"2012","journal-title":"Psychiatria Danubina"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2005.04.010"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.2014.963057"},{"key":"e_1_2_7_17_1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0924-9338(02)00004-4","article-title":"Which neuroleptic would psychiatrists take for themselves or their relatives?","volume":"18","author":"Steinert T.","year":"2003","journal-title":"European Psychiatry"},{"key":"e_1_2_7_18_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1258\/rsmsmj.52.1.17","article-title":"\u201cDo unto others as\u2026\u201d \u2013 Which treatments do psychiatrists prefer?","volume":"52","author":"Taylor M.","year":"2007","journal-title":"Scottish Medical Journal"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6394(1999)9:3<107::AID-DA2>3.0.CO;2-T"},{"key":"e_1_2_7_20_1","first-page":"346","article-title":"Clinicians are right not to like Cohen's \u03ba","volume":"12","author":"Vet H. C.","year":"2013","journal-title":"BMJ"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/da.10065"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200015060-00002"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2005.04.012"}],"container-title":["Human Psychopharmacology: Clinical and Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.2643","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hup.2643","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T01:44:50Z","timestamp":1695865490000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hup.2643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,20]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1002\/hup.2643"],"URL":"https:\/\/doi.org\/10.1002\/hup.2643","archive":["Portico"],"relation":{},"ISSN":["0885-6222","1099-1077"],"issn-type":[{"value":"0885-6222","type":"print"},{"value":"1099-1077","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,20]]},"article-number":"e2643"}}